827 related articles for article (PubMed ID: 28711318)
1. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns).
Stocker M; van Herk W; El Helou S; Dutta S; Fontana MS; Schuerman FABA; van den Tooren-de Groot RK; Wieringa JW; Janota J; van der Meer-Kappelle LH; Moonen R; Sie SD; de Vries E; Donker AE; Zimmerman U; Schlapbach LJ; de Mol AC; Hoffman-Haringsma A; Roy M; Tomaske M; Kornelisse RF; van Gijsel J; Visser EG; Willemsen SP; van Rossum AMC;
Lancet; 2017 Aug; 390(10097):871-881. PubMed ID: 28711318
[TBL] [Abstract][Full Text] [Related]
2. Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: A multi-centre randomized superiority and non-inferiority Intervention Study.
Stocker M; Hop WC; van Rossum AM
BMC Pediatr; 2010 Dec; 10():89. PubMed ID: 21143869
[TBL] [Abstract][Full Text] [Related]
3. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
5. Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates.
Geraerds AJLM; van Herk W; Stocker M; El Helou S; Dutta S; Fontana MS; Schuerman FABA; van den Tooren-de Groot RK; Wieringa J; Janota J; van der Meer-Kappelle LH; Moonen R; Sie SD; de Vries E; Donker AE; Zimmerman U; Schlapbach LJ; de Mol AC; Hoffman-Haringsma A; Roy M; Tomaske M; Kornelisse RF; van Gijsel J; Visser EG; van Rossum AMC; Polinder S
Crit Care; 2021 Oct; 25(1):367. PubMed ID: 34670582
[TBL] [Abstract][Full Text] [Related]
6. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
[TBL] [Abstract][Full Text] [Related]
7. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
[TBL] [Abstract][Full Text] [Related]
8. Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.
Hill LF; Clements MN; Turner MA; Donà D; Lutsar I; Jacqz-Aigrain E; Heath PT; Roilides E; Rawcliffe L; Alonso-Diaz C; Baraldi E; Dotta A; Ilmoja ML; Mahaveer A; Metsvaht T; Mitsiakos G; Papaevangelou V; Sarafidis K; Walker AS; Sharland M;
Lancet Child Adolesc Health; 2022 Jan; 6(1):49-59. PubMed ID: 34843669
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.
Keij FM; Kornelisse RF; Hartwig NG; van der Sluijs-Bens J; van Beek RHT; van Driel A; van Rooij LGM; van Dalen-Vink I; Driessen GJA; Kenter S; von Lindern JS; Eijkemans M; Stam-Stigter GM; Qi H; van den Berg MM; Baartmans MGA; van der Meer-Kappelle LH; Meijssen CB; Norbruis OF; Heidema J; van Rossem MC; den Butter PCP; Allegaert K; Reiss IKM; Tramper-Stranders GA
Lancet Child Adolesc Health; 2022 Nov; 6(11):799-809. PubMed ID: 36088952
[TBL] [Abstract][Full Text] [Related]
10. Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial.
Bloos F; Trips E; Nierhaus A; Briegel J; Heyland DK; Jaschinski U; Moerer O; Weyland A; Marx G; Gründling M; Kluge S; Kaufmann I; Ott K; Quintel M; Jelschen F; Meybohm P; Rademacher S; Meier-Hellmann A; Utzolino S; Kaisers UX; Putensen C; Elke G; Ragaller M; Gerlach H; Ludewig K; Kiehntopf M; Bogatsch H; Engel C; Brunkhorst FM; Loeffler M; Reinhart K;
JAMA Intern Med; 2016 Sep; 176(9):1266-76. PubMed ID: 27428731
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
[TBL] [Abstract][Full Text] [Related]
13. A procalcitonin-based algorithm to guide antibiotic use in patients with acute pancreatitis (PROCAP): a single-centre, patient-blinded, randomised controlled trial.
Siriwardena AK; Jegatheeswaran S; Mason JM;
Lancet Gastroenterol Hepatol; 2022 Oct; 7(10):913-921. PubMed ID: 35863358
[TBL] [Abstract][Full Text] [Related]
14. Does a procalcitonin-guided approach to term and late-preterm neonates with suspected early-onset sepsis safely decrease unnecessary antibiotic exposure?
Hooven TA
Acta Paediatr; 2018 Feb; 107(2):359-360. PubMed ID: 29131403
[No Abstract] [Full Text] [Related]
15. PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): study protocol for a randomised controlled trial.
Siriwardena AK; Jegatheeswaran S; Mason JM; Baltatzis M; Chan A; Sheen AJ; O'Reilly D; Jamdar S; Deshpande R; de Liguori Carino N; Satyadas T; Qamruddin A; Hayden K; Parker MJ; Butler J; Rajai A; McIntyre B
Trials; 2019 Jul; 20(1):463. PubMed ID: 31358032
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin to guide antibiotic therapy in the ICU.
Bréchot N; Hékimian G; Chastre J; Luyt CE
Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S19-24. PubMed ID: 26607343
[TBL] [Abstract][Full Text] [Related]
17. Early versus late parenteral nutrition in critically ill, term neonates: a preplanned secondary subgroup analysis of the PEPaNIC multicentre, randomised controlled trial.
van Puffelen E; Vanhorebeek I; Joosten KFM; Wouters PJ; Van den Berghe G; Verbruggen SCAT
Lancet Child Adolesc Health; 2018 Jul; 2(7):505-515. PubMed ID: 30169323
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial.
Jeon K; Suh JK; Jang EJ; Cho S; Ryu HG; Na S; Hong SB; Lee HJ; Kim JY; Lee SM
J Korean Med Sci; 2019 Apr; 34(14):e110. PubMed ID: 30977312
[TBL] [Abstract][Full Text] [Related]
19. [Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis].
Aravena M
Rev Chilena Infectol; 2017 Oct; 34(5):522. PubMed ID: 29488601
[No Abstract] [Full Text] [Related]
20. Reduction of Duration of Antibiotic Therapy for Suspected Early-Onset Sepsis in Late-Preterm and Term Newborns After Implementation of a Procalcitonin-Guided Algorithm: A Population-Based Study in Central Switzerland.
Zihlmann-Ji J; Braun C; Buettcher M; Hodel M; Lehnick D; Stocker M
Front Pediatr; 2021; 9():702133. PubMed ID: 34368029
[No Abstract] [Full Text] [Related]
[Next] [New Search]
